(Q45874082)

English

Clinical trials update: highlights of the scientific sessions of the American Heart Association year 2000: Val HeFT, COPERNICUS, MERIT, CIBIS-II, BEST, AMIOVIRT, V-MAC, BREATHE, HEAT, MIRACL, FLORIDA, VIVA and the first human cardiac skeletal muscle

scientific article published in January 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/11163746

Clinical trials update: highlights of the scientific sessions of the American Heart Association year 2000: Val HeFT, COPERNICUS, MERIT, CIBIS-II, BEST, AMIOVIRT, V-MAC, BREATHE, HEAT, MIRACL, FLORIDA, VIVA and the first human cardiac skeletal muscle (English)

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/11163746

0 references

6

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/11163746

2

object named as

K K Witte

1 reference

Europe PubMed Central

17 December 2017

author name string

S D Thackray

1

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/11163746

A Khand

3

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/11163746

A Dunn

4

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/11163746

A L Clark

5

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/11163746

publication date

1 January 2001

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/11163746

European Journal of Heart Failure

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/11163746

3

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/11163746

1

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/11163746

117-124

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/11163746

Rationale and design of the Valsartan Heart Failure Trial: a large multinational trial to assess the effects of valsartan, an angiotensin-receptor blocker, on morbidity and mortality in chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900145-8

21 January 2018

Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900145-8

21 January 2018

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900145-8

21 January 2018

Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900145-8

21 January 2018

Clinical trials update: IMPROVEMENT-HF, COPERNICUS, MUSTIC, ASPECT-II, APRICOT and HEART.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900145-8

21 January 2018

New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900145-8

21 January 2018

Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900145-8

21 January 2018

Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900145-8

21 January 2018

Clinical trials in coronary angiogenesis: issues, problems, consensus: An expert panel summary

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900145-8

21 January 2018

The Carvedilol Hibernation Reversible Ischaemia Trial; Marker of Success (CHRISTMAS)

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900145-8

21 January 2018

Baseline demographics of the Valsartan Heart Failure Trial. Val-HeFT Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900145-8

21 January 2018

Update of REACH-1 and MERIT-HF clinical trials in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900145-8

21 January 2018

Update of recent clinical trials in heart failure and myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900145-8

21 January 2018

Update of ELITE-II, BEST, CHAMP, and IMPRESS clinical trials in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900145-8

21 January 2018

Effect of concomitant digoxin and carvedilol therapy on mortality and morbidity in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900145-8

21 January 2018

Sudden death in heart failure: vascular or electrical?

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900145-8

21 January 2018

Identifiers

10.1016/S1388-9842(00)00145-8

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/11163746

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/11163746

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45874082&oldid=1361132483"